Clinical Trials

Galway University Launches Groundbreaking Cancer Therapy Trials
Research & Development Galway University Launches Groundbreaking Cancer Therapy Trials

In a world where cancer remains one of the most formidable health challenges, a beacon of hope emerges from western Ireland with an innovative approach that could redefine treatment for some of the most resistant cases. The University of Galway, in partnership with leading organizations, has

UK Cancer Survival Slows: Urgent Call for National Plan
Research & Development UK Cancer Survival Slows: Urgent Call for National Plan

The landscape of cancer care in the UK stands at a critical crossroads, where decades of hard-won progress in survival rates are now showing signs of stagnation, raising alarm among researchers and health advocates alike, as they grapple with the implications of this troubling trend. A

Can CLAAS AcuFORM Transform Stroke Prevention for AFib?
Research & Development Can CLAAS AcuFORM Transform Stroke Prevention for AFib?

In a world where atrial fibrillation (AFib) affects millions, increasing the risk of stroke by up to five times, the search for effective prevention strategies has never been more urgent, especially as traditional anticoagulant therapies often present significant challenges for patients with

Why Are Rural ERs Operating Without On-Site Doctors?
Research & Development Why Are Rural ERs Operating Without On-Site Doctors?

Imagine a small town in rural America, where the nearest hospital is the only lifeline for emergencies, yet no doctor is present when a critical situation unfolds, leaving patients at risk. This scenario is becoming alarmingly common as rural emergency rooms (ERs) across the U.S. increasingly

Can Ianalumab Revolutionize ITP Treatment for Patients?
Research & Development Can Ianalumab Revolutionize ITP Treatment for Patients?

For countless individuals grappling with immune thrombocytopenia (ITP), a disorder defined by dangerously low platelet counts that heighten the risk of severe bleeding and bruising, the current treatment landscape often feels like an unending cycle of hospital visits and disruptive therapies.

Novel MET Inhibition Boosts Immunotherapy for Lung Cancer
Research & Development Novel MET Inhibition Boosts Immunotherapy for Lung Cancer

Small cell lung cancer (SCLC) represents one of the most formidable challenges in oncology, characterized by its aggressive nature and a disheartening prognosis that leaves many patients with limited hope. Accounting for roughly 15% of lung cancer cases, this disease spreads rapidly and often

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later